Kynam Capital Management, LP Portfolio Holdings
Kynam Capital Management, LP
- $953 Million
- Q1 2024
Kynam Capital Management, LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $953 Million distributed in 23 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $183M, Syndax Pharmaceuticals Inc with a value of $135M, Celldex Therapeutics, Inc. with a value of $122M, Vera Therapeutics, Inc. with a value of $65.8M, and Cogent Biosciences, Inc. with a value of $57.1M.
Examining the 13F form we can see an increase of $59.1M in the current position value, from $894M to 953M.
Kynam Capital Management, LP is based out at Princeton, NJ
Below you can find more details about Kynam Capital Management, LP portfolio as well as his latest detailed transactions.